AVIVA Natural Supplements

FDA inspections

FDA lists 4 food or dietary supplement inspections at facilities matching AVIVA Natural Supplements, from 2022 to 2026, as of Oct 22, 2026. 3 found no objectionable conditions and 1 led FDA to recommend official action.

• No action indicated · No objectionable conditions found

  Inspected May 19, 2026

  New Brunswick, New Jersey

  FEI 3022297128

• Official action indicated · Regulatory or administrative action recommended

  Inspected Feb 27, 2026

  New Brunswick, New Jersey

  13 citations posted:

  • Hygienic practices (21 CFR 111.10(b))
  • Physical plant - design (21 CFR 111.20(d))
  • Specifications - components (21 CFR 111.70(b))
  • Specifications - finished dietary supplement (21 CFR 111.70(e))

  See all 13 citations

  • Hygienic practices (21 CFR 111.10(b))

    Your personnel did not use hygienic practices to the extent necessary to protect against contamination of components, dietary supplements, or contact surfaces.

  • Physical plant - design (21 CFR 111.20(d))

    Your physical plant was not designed in a manner that prevents contamination of components and dietary supplements.

  • Specifications - components (21 CFR 111.70(b))

    For component(s) used in the manufacture of a dietary supplement, you did not establish necessary specifications to ensure the specifications for purity, strength, and composition of the dietary supplement are met and limits on contamination to ensure the quality of the dietary supplement.

  • Specifications - finished dietary supplement (21 CFR 111.70(e))

    You did not establish product specifications for identity, purity and strength.

  • Component - qualify supplier (21 CFR 111.75(a)(2)(ii)(A))

    You did not qualify a supplier of a component by establishing the reliability of the supplier's certificate of analysis through confirmation of the results of their tests or examinations.

  • Component - certificate of analysis (21 CFR 111.75(a)(2)(ii)(B))

    The certificate of analysis for a component does not include a description of the test or examination method(s) used.

  • Specifications met - verify; finished batch (21 CFR 111.75(c))

    You did not verify that your finished batch of dietary supplement meets product specifications for identity, purity, strength and composition.

  • Quality control - Laboratory control processes; production, process control (21 CFR 111.110)

    Your quality control operations did not include reviewing and approving laboratory control processes associated with the production and process control system and reviewing and approving the results of required tests and examinations.

  • Quality control production, process control; material review, disposition (21 CFR 111.113(a)(1))

    Your quality control personnel did not conduct a material review and make a disposition decision for a specification established for the production and process control system that was not met.

  • Master manufacturing record - record requirements (21 CFR 111.210)

    Your master manufacturing record did not include all required information.

  • Batch record - required information (21 CFR 111.260)

    Your batch production record did not include all required information.

  • Standard reference materials; criteria for selecting (21 CFR 111.315(d))

    You did not establish laboratory control processes for use of criteria for selecting standard reference materials used in performing tests and examinations.

  • Examination, testing; scientifically valid (21 CFR 111.320(b))

    You did not identify and use an appropriate scientifically valid method for each established specification for which testing or examination is required to determine whether the specification was met.

  FEI 3022297128

• No action indicated · No objectionable conditions found

  Inspected Apr 14, 2022

  New Brunswick, New Jersey

  FEI 3022297128

• No action indicated · No objectionable conditions found

  Inspected Apr 14, 2022

  New Brunswick, New Jersey

  FEI 3022297128

We match FDA inspections to companies by facility ZIP code (or city outside the US) and company name, so an inspection filed under a different name won’t appear here. FDA publishes final classifications only, and holds some back while enforcement is pending. Posted citations may differ from FDA’s final findings. FDA Data Dashboard · How we check